Exploring bedside clinical features of parkinsonism: A focus on differential diagnosis
- PMID: 30502095
- DOI: 10.1016/j.parkreldis.2018.11.005
Exploring bedside clinical features of parkinsonism: A focus on differential diagnosis
Abstract
The proper diagnosis of parkinsonian disorders usually involves three steps: identifying core features of parkinsonism; excluding other causes; and collating supportive evidence based on clinical signs or investigations. While the recognition of cardinal parkinsonian features is usually straightforward, the appreciation of clinical features suggestive of specific parkinsonian disorders can be challenging, and often requires greater experience and skills. In this review, we outline the clinical features that are relevant to the differential diagnosis of common neurodegenerative parkinsonian disorders, including Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. We aim to make this process relatable to clinicians-in-practice, therefore, have categorised the list of clinical features into groups according to the typical sequence on how clinicians would elicit them during the examination, starting with observation of facial expression and clinical signs of the face, spotting eye movement abnormalities, examination of tremors and jerky limb movements, and finally, examination of posture and gait dysfunction. This review is not intended to be comprehensive. Rather, we have focused on the most common clinical signs that are potentially key to making the correct diagnosis and those that do not require special skills or training for interpretation. Evidence is also provided, where available, such as diagnostic criteria, consensus statements, clinicopathological studies or large multi-centre registries. Pitfalls are also discussed when relevant to the diagnosis. While no clinical signs are pathognomonic for certain parkinsonian disorders, certain clinical clues may assist in narrowing a differential diagnosis and tailoring focused investigations for the individual patient.
Keywords: Atypical parkinsonian disorders; Corticobasal degeneration; Differential diagnosis; Multiple system atrophy; Parkinson's disease; Parkinsonism; Progressive supranuclear palsy.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Red flags phenotyping: A systematic review on clinical features in atypical parkinsonian disorders.Parkinsonism Relat Disord. 2019 Feb;59:82-92. doi: 10.1016/j.parkreldis.2018.10.009. Epub 2018 Oct 6. Parkinsonism Relat Disord. 2019. PMID: 30409560
-
The differential diagnosis of Parkinson's disease.Eur J Neurol. 2002 Nov;9 Suppl 3:23-30. doi: 10.1046/j.1468-1331.9.s3.3.x. Eur J Neurol. 2002. PMID: 12464118 Review.
-
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study.Parkinsonism Relat Disord. 2018 Nov;56:33-40. doi: 10.1016/j.parkreldis.2018.06.015. Epub 2018 Jun 8. Parkinsonism Relat Disord. 2018. PMID: 29910157
-
Differential diagnosis of parkinsonism with visual inspection of posture and gait in the early stage.Gait Posture. 2014 Apr;39(4):1138-41. doi: 10.1016/j.gaitpost.2014.01.004. Epub 2014 Jan 15. Gait Posture. 2014. PMID: 24485920
-
Visual signs and symptoms of corticobasal degeneration.Clin Exp Optom. 2016 Nov;99(6):498-506. doi: 10.1111/cxo.12429. Epub 2016 Aug 23. Clin Exp Optom. 2016. PMID: 27553583 Review.
Cited by
-
Freezing of saccades in dopa-responsive parkinsonian syndrome.Am J Ophthalmol Case Rep. 2021 May 23;23:101124. doi: 10.1016/j.ajoc.2021.101124. eCollection 2021 Sep. Am J Ophthalmol Case Rep. 2021. PMID: 34169178 Free PMC article.
-
Comparison of inflammatory biomarker levels in neurodegenerative proteinopathies: a case-control study.J Neural Transm (Vienna). 2025 Jun;132(6):811-826. doi: 10.1007/s00702-025-02902-6. Epub 2025 Mar 3. J Neural Transm (Vienna). 2025. PMID: 40029428 Free PMC article.
-
Simple biomarkers to distinguish Parkinson's disease from its mimics in clinical practice: a comprehensive review and future directions.Front Neurol. 2024 Sep 19;15:1460576. doi: 10.3389/fneur.2024.1460576. eCollection 2024. Front Neurol. 2024. PMID: 39364423 Free PMC article. Review.
-
The Interaction Between Nutraceuticals and Gut Microbiota: a Novel Therapeutic Approach to Prevent and Treatment Parkinson's Disease.Mol Neurobiol. 2024 Nov;61(11):9078-9109. doi: 10.1007/s12035-024-04151-2. Epub 2024 Apr 8. Mol Neurobiol. 2024. PMID: 38587699 Review.
-
Uncovering Potential Biomarkers and Constructing a Prediction Model Associated with Iron Metabolism in Parkinson's Disease.Neuropsychiatr Dis Treat. 2025 Feb 28;21:437-449. doi: 10.2147/NDT.S511671. eCollection 2025. Neuropsychiatr Dis Treat. 2025. PMID: 40041883 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical